ProjectHealth and Medicines Sector Market Assessment
Southern Africa is suffering a double burden of disease: a high rate of communicable diseases like HIV/AIDs and tuberculosis, and an increase of non-communicable lifestyle diseases. Access to appropriate, affordable, and quality health care and medicines is one of the building blocks of an effective health system. The public health sector is often overburdened, and while the private sector is already playing a role in providing health care, it is currently mostly limited to urban and high-income populations. There are great opportunities for the private health sector to better complement the public health system and broaden its access to a wider share of the population.
The African Medicines Impact Investment Fund (AMIIF), together with the Cadiz ASSIST Fund, aims not only to support innovative solutions from private sector enterprises that can operate at critical points in the health and medicines value chain, but also to harness private sector investment.
The aim of this project was to support AMIIF's investment hypothesis to attract investors. The geographic scope of investments was phased in several stages focusing on the following countries in this first stage:
- South Africa
This project had two major end products:
- Market assessment per country: these country reports include macro economic health-related data, a brief overview of the private sector and its role in providing healthcare access, and spotlights on private enterprises contributing to healthcare access in each country. The results were verified through a consultation workshop with key stakeholder on Nov 15, 2013 in Johannesburg, South Africa.
- Investment briefs: Four to five promising investment opportunities were identified per country from a database with potential SMEs. Investment briefs on each of these will include important information for potential investors, such as founding year, scalability, operating budgets, and impact data.